Defiance Autism Impact ETF
ASD
NASDAQ Global Market- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Defiance Autism Impact ETF (ASD) is an exchange-traded fund that seeks to track the performance of publicly traded companies developing products, services, therapies, diagnostics, technologies, educational tools and support solutions addressing autism and related conditions, with a strategy that emphasizes autism-focused impact while pursuing capital appreciation. The fund primarily invests at least 80% of its net assets in Autism Impact Companies and generally employs a replication approach to achieve its objective, aiming to mirror the performance of a defined index related to autism impact activites. It is managed by Defiance ETFs, part of Defiance Investments, and is listed in the United States, with holdings weighted toward companies involved in healthcare, diagnostics, therapeutics, education, assistive technologies, and related support services that contribute to autism diagnosis, treatment, and quality of life improvements. The fund’s structure includes a charitable element, pledging profits to autism-related causes, and it seeks to allocate a substantial portion of net profits to nonprofit organizations supporting autism initiatives in its initial years, followed by ongoing annual donations consistent with policy disclosures. The fund’s geographic footprint includes global companies contributing to autism impact, with a focus on U.S. listings and global issuers that meet the fund’s investment criteria. Founding and headquarters details: launched in 2026 and managed from Defiance’s headquarters in the United States, with strategic distribution through Defiance’s network and partnerships. Subsidiaries and parent relationships align with Defiance Investments, which oversees the ETF’s governance, compliance and operational framework. The latest changes include the fund’s launch in 2026, formation of a partnership-based index tracking framework, and a policy to donate profits to autism-focused causes, reflecting a strategic shift toward impact-driven investment while maintaining a traditional ETF structure. The fund’s investment process combines index replication with ongoing screening for autism-related product categories, engaging with index providers and asset management collaborations to ensure alignment with the defined autism impact criteria. The product suite comprises a single primary offering—the ASD ETF—complemented by related research, annual impact reporting, and ongoing investor communications detailing holdings, sector exposure, and geographic distribution. The target markets span institutional and high-net-worth investors seeking thematic exposure to autism-related innovation, with product transparency through periodic disclosures of top holdings, sector weights and regional allocations. The fund’s governance emphasizes fiduciary responsibility, with disclosures around risk factors, performance history, and the charitable donation framework embedded in the fund prospectus and periodic reports. This combination positions ASD as a focused, impact-oriented vehicle within the broader thematic ETF landscape, targeting investors who seek both growth potential and measurable social impact aligned with autism awareness and support efforts.